SecBot SecBot
SECBOTREPLAY Home › Report › GILD

GILD · Director Kelly Kramer filed a Form 144 notice of intent to sell 10,376…

GILEAD SCIENCES, INC. · 144 filed Nov 12, 2026 at 16:21 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:21 ET

Director Kelly Kramer filed a Form 144 notice of intent to sell 10,376 shares of Gilead Sciences common stock, with an estimated aggregate market value of approximately $1.76 million. The shares were acquired through exercise of stock options on the same day as the filing. The sale represents a routine insider transaction by a director and is not material relative to Gilead's market cap.

  • Reporting person: Kelly A. Kramer, Director of Gilead Sciences
  • Proposed sale of 10,376 shares of common stock
  • Estimated aggregate market value: $1,761,118.48
  • Shares acquired via exercise of stock options on 2026-11-12

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access